The Asia-Pacific epilepsy devices market is expected to grow with an 8.05% CAGR by 2030, and is anticipated to generate $314.04 million during the estimated years 2022-2030.
ASIA-PACIFIC EPILEPSY DEVICES MARKET FORECAST 2022-2030
Asia-Pacific Epilepsy Devices Market by Product Type (Conventional Devices, Wearable Devices, Implantable Devices) Market by Technology (Vagus Nerve Stimulation, Deep Brain Stimulation, Accelerometry, Responsive Neurostimulation) Market by Detection & Prediction Devices Type (Electroencephalogram, Intracranial Eeg, Surface Electromyography, Electrocardiography, Video Detection Systems, Electrodermal Activity, Implanted Advisory Systems, Other Detection & Prediction Device Types) Market by End-user (Hospitals & Clinics, Neurology Centers, Home Care Settings, Other End-users) By Geography
The Asia-Pacific epilepsy devices market is expected to grow with an 8.05% CAGR by 2030, and is anticipated to generate $314.04 million during the estimated years 2022-2030.
The high prevalence of epilepsy in Asia-Pacific is expected to boost the market growth. According to the World Health Organization, in June 2019, nearly 80% of people with epilepsy lived in low and middle-income countries. Furthermore, the region’s high presence of the older population is also driving the market. The Asia-Pacific region is also attracting various global players by providing good possibilities for training and research and offering favorable initiatives through national Ministries of Health to identify the needs and promote prevention, research, treatment, care services, training, and education.
To know more about this report, request a free sample copy
The Asia-Pacific epilepsy devices market growth analysis includes the evaluation of Japan, India, Taiwan, Australia & New Zealand, China, South Korea, Singapore, Indonesia, and Rest of Asia-Pacific. Even though China’s economy has grown significantly and its healthcare system has improved over the past few decades, the country’s diverse development and demographic patterns make it difficult to determine the prevalence of epilepsy on a national scale. Epilepsy knowledge has grown among the general public due to economic expansion, fast urbanization, and demographic changes, including an aging population. The number of people seeking an epilepsy diagnosis and treatment is rising, raising the need for epilepsy equipment.
Additionally, in Japan, the seizure and intellectual prognosis of childhood-onset epilepsy have improved progressively due to medical and surgical treatment developments. Recent advancements in genetic, metabolic, and neuroimaging techniques have altered epilepsy classification more thoroughly, encompassing numerous distinct childhood-onset epilepsy syndromes that are unknown to even adult specialists and obstruct a seamless transition to adult care. The demand for epilepsy gadgets in the area has increased due to these advances.
The Asia-Pacific epilepsy devices market assessment includes segmentation by product type, technology, end-user, and detection & prediction devices type. Market by detection & prediction devices type covers electrocardiography, surface electromyography, electrodermal activity, intracranial EEG, video detection systems, electroencephalogram, implanted advisory systems, and other detection & prediction device types.
Electroencephalography (EEG) is significant in identifying & diagnosing the presence of epileptiform activity, contributing to syndromic and classification diagnosis. The conventional approach to EEG requires a long set‐up procedure involving montage selection, gel application, connection selection, electrode attachment, and skin preparation. In addition, the in‐hospital scalp‐EEG solution is uncomfortable for patients, removes the patient from their natural environment, is expensive, and is time‐consuming.
Further, given the limited availability and clinical importance of conventional EEG, there is growing interest in wearable EEG solutions that allow long‐term monitoring. The mobile EEG also provides acceptable performance compared to conventional ones. As a result, various manufacturers have started producing wireless EEG and dry electrodes to reduce the negative impact of stigma.
Key companies in the Asia-Pacific epilepsy devices market include Nihon Kohden Corporation, Koninklijke Philips NV, etc.
Nihon Kohden Corporation is engaged in the development, production, sales, and service of medical devices. Their product portfolio offers patient monitoring, sleep assessment, neurology, and cardiology instrumentation. The company’s key technologies include physiological measuring equipment, patient monitors, treatment equipment, medical support systems and in-vitro diagnostic equipment. The company operates across Asia-Pacific, Europe, the Americas, and the Middle East & Africa. Nihon Kohden Corporation is headquartered in Tokyo, Japan.
Trackit Ambulatory EEG from Nihon Kohden Corporation is an ambulatory system ideal for EEG recording applications in children and adults. It is light, transportable and simple to configure and incorporates built-in oximetry, universal sensor inputs and 4 DC channels.
Report Synopsis
Report Scope | Details |
| Market Forecast Years | 2022-2030 |
| Base Year | 2021 |
| Market Historical Years | 2018-2021 |
| Forecast Units | Revenue ($ Million) |
| Segments Analyzed | Product Type, Technology, End-User, Detection & Prediction Devices Type |
| Countries Analyzed | China, Japan, India, South Korea, Taiwan, Singapore, Indonesia, and Rest of Asia-Pacific |
| Companies Analyzed | Boston Scientific Corporation, Cadwell Industries Inc, Compumedics Limited, Drägerwerk AG & Co KGaA, Empatica Inc, Koninklijke Philips NV, LivaNova PLC, Medtronic PLC, Natus Medical Incorporated, Nihon Kohden Corporation, NeuroPace Inc, Neurosoft, Shenzhen Mindray Bio-Medical Electronics Co Ltd |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- SOARING OCCURRENCES OF EPILEPSY GLOBALLY
- ONSET OF EPILEPSY IN ELDERLY PEOPLE
- MITIGATION OF EPILEPSY USING EARLY DIAGNOSIS
- SURGE IN POST-TRAUMATIC EPILEPSY WITH RISING BRAIN INJURY CASES
- KEY RESTRAINTS
- MISPERCEPTIONS AND MISINFORMATION ABOUT EPILEPSY
- SHORTAGE OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON EPILEPSY DEVICES MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- VALUE CHAIN ANALYSIS
- KEY BUYING CRITERIA
- COMFORT & USABILITY
- PRODUCT FEATURES
- CONFIDENTIALITY
- REGULATORY FRAMEWORK
- MARKET BY PRODUCT TYPE
- CONVENTIONAL DEVICES
- WEARABLE DEVICES
- WATCHES
- BRACELETS
- CAMERA DEVICES
- MATTRESS DEVICES
- ANTI-SUFFOCATION PILLOWS
- OTHER WEARABLE DEVICES
- IMPLANTABLE DEVICES
- MARKET BY TECHNOLOGY
- VAGUS NERVE STIMULATION
- DEEP BRAIN STIMULATION
- MOVEMENT DISORDERS
- EPILEPSY
- ACCELEROMETRY
- RESPONSIVE NEUROSTIMULATION
- MARKET BY DETECTION & PREDICTION DEVICES TYPE
- ELECTROENCEPHALOGRAM
- INTRACRANIAL EEG
- SURFACE ELECTROMYOGRAPHY
- ELECTROCARDIOGRAPHY
- VIDEO DETECTION SYSTEMS
- ELECTRODERMAL ACTIVITY
- IMPLANTED ADVISORY SYSTEMS
- OTHER DETECTION & PREDICTION DEVICE TYPES
- MARKET BY END-USER
- HOSPITALS & CLINICS
- NEUROLOGY CENTERS
- HOME CARE SETTINGS
- OTHER END-USERS
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET ESTIMATES & SIZES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- SINGAPORE
- TAIWAN
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS
- COMPANY PROFILES
- BOSTON SCIENTIFIC CORPORATION
- CADWELL INDUSTRIES INC
- COMPUMEDICS LIMITED
- DRÄGERWERK AG & CO KGAA
- EMPATICA INC
- KONINKLIJKE PHILIPS NV
- LIVANOVA PLC
- MEDTRONIC PLC
- NATUS MEDICAL INCORPORATED
- NEUROPACE INC
- NEUROSOFT
- NIHON KOHDEN CORPORATION
- SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: ASIA-PACIFIC MARKET SNAPSHOT – EPILEPSY DEVICES
TABLE 2: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
TABLE 3: EXAMPLES OF MOBILE EEG DEVICES
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: LEADING PLAYERS OPERATING IN ASIA-PACIFIC EPILEPSY DEVICES MARKET
TABLE 20: LIST OF ACQUISITIONS
TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 22: LIST OF PARTNERSHIPS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: ASIA-PACIFIC EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021
FIGURE 8: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY CONVENTIONAL DEVICES, 2022-2030 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2030 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY WEARABLE DEVICES, IN 2021
FIGURE 11: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2030 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2030 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2030 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2030 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2030 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2030 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2030 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021
FIGURE 19: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2030 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2030 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DEEP BRAIN STIMULATION, IN 2021
FIGURE 22: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2030 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2030 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ACCELEROMETRY, 2022-2030 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2030 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DETECTION & PREDICTION DEVICES TYPE, IN 2021
FIGURE 27: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2030 (IN $ MILLION)
FIGURE 28: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2030 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 30: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2030 (IN $ MILLION)
FIGURE 32: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2030 (IN $ MILLION)
FIGURE 33: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2030 (IN $ MILLION)
FIGURE 34: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY OTHER DETECTION & PREDICTION DEVICE TYPES, 2022-2030 (IN $ MILLION)
FIGURE 35: ASIA-PACIFIC EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
FIGURE 36: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2030 (IN $ MILLION)
FIGURE 37: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2030 (IN $ MILLION)
FIGURE 38: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY HOME CARE SETTINGS, 2022-2030 (IN $ MILLION)
FIGURE 39: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)
FIGURE 40: ASIA-PACIFIC EPILEPSY DEVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)
FIGURE 41: CHINA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 42: JAPAN EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 43: INDIA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 44: SOUTH KOREA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 45: INDONESIA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 46: SINGAPORE EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 47: TAIWAN EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 48: AUSTRALIA & NEW ZEALAND EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 49: REST OF ASIA-PACIFIC EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET ESTIMATES & SIZES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- SINGAPORE
- TAIWAN
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- MARKET BY PRODUCT TYPE
- CONVENTIONAL DEVICES
- WEARABLE DEVICES
- WATCHES
- BRACELETS
- CAMERA DEVICES
- MATTRESS DEVICES
- ANTI-SUFFOCATION PILLOWS
- OTHER WEARABLE DEVICES
- IMPLANTABLE DEVICES
- MARKET BY TECHNOLOGY
- VAGUS NERVE STIMULATION
- DEEP BRAIN STIMULATION
- MOVEMENT DISORDERS
- EPILEPSY
- ACCELEROMETRY
- RESPONSIVE NEUROSTIMULATION
- MARKET BY DETECTION & PREDICTION DEVICES TYPE
- ELECTROENCEPHALOGRAM
- INTRACRANIAL EEG
- SURFACE ELECTROMYOGRAPHY
- ELECTROCARDIOGRAPHY
- VIDEO DETECTION SYSTEMS
- ELECTRODERMAL ACTIVITY
- IMPLANTED ADVISORY SYSTEMS
- OTHER DETECTION & PREDICTION DEVICE TYPES
- MARKET BY END-USER
- HOSPITALS & CLINICS
- NEUROLOGY CENTERS
- HOME CARE SETTINGS
- OTHER END-USERS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.